Johns Hopkins ABX Guide
Cefaclor
Cefaclor is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
- Lower respiratory tract infections including pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus (author’s comment: not a first-line agent)
- Pharyngitis and tonsillitis caused by Streptococcus pyogenes (PCN is the drug of choice).
- Pyelonephritis and cystitis caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative staphylococci (author’s comment: not a first-line agent)
- Skin and skin structure infections caused by Staphylococcus aureus (MSSA) and Streptococcus pyogenes
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
- Lower respiratory tract infections including pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus (author’s comment: not a first-line agent)
- Pharyngitis and tonsillitis caused by Streptococcus pyogenes (PCN is the drug of choice).
- Pyelonephritis and cystitis caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative staphylococci (author’s comment: not a first-line agent)
- Skin and skin structure infections caused by Staphylococcus aureus (MSSA) and Streptococcus pyogenes
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: July 8, 2018
Citation
Avdic, Edina, and Paul A Pham. "Cefaclor." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor.
Avdic E, Pham PA. Cefaclor. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor. Accessed January 19, 2021.
Avdic, E., & Pham, P. A. (2018). Cefaclor. In Johns Hopkins ABX Guide. The Johns Hopkins University. Retrieved January 19, 2021, from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor
Avdic E, Pham PA. Cefaclor [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2021 January 19]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefaclor
ID - 540084
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2018/07/08/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
